Molgramostim (Shenzhen Forward Biotechnology)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMolgramostim (Shenzhen Forward Biotechnology)

Drug Alias NameN/A

ClassificationBiologics

Mechanisms of ActionGranulocyte-macrophage colony-stimulating factor receptor antagonistsGranulocyte-macrophage colony-stimulating factor receptor stimulants

TargetsGranulocyte-macrophage colony-stimulating factor receptor

Therapy Area/IndicationsSkin UlcerDermatitis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaPending

Originator CompaniesShenzhen Forward Pharmaceuticals Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesShenzhen Forward Pharmaceuticals Co Ltd

Active IndicationsN/A

Inactive IndicationsSkin UlcerDermatitis

Other Information

ATC CodeN/A